Cargando…
AICAR inhibits NFκB DNA binding independently of AMPK to attenuate LPS-triggered inflammatory responses in human macrophages
5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) is an established pharmacological activator of AMP-activated protein kinase (AMPK). Both, AICAR and AMPK were reported to attenuate inflammation. However, AICAR is known for many AMPK-independent effects, although the mechanisms remain inco...
Autores principales: | Kirchner, Johannes, Brüne, Bernhard, Namgaladze, Dmitry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5958102/ https://www.ncbi.nlm.nih.gov/pubmed/29773845 http://dx.doi.org/10.1038/s41598-018-26102-3 |
Ejemplares similares
-
AMPK-independent inhibition of human macrophage ER stress response by AICAR
por: Boß, Marcel, et al.
Publicado: (2016) -
Pharmacological Activation of p53 during Human Monocyte to Macrophage Differentiation Attenuates Their Pro-Inflammatory Activation by TLR4, TLR7 and TLR8 Agonists
por: Namgaladze, Dmitry, et al.
Publicado: (2021) -
AICAR-Induced AMPK Activation Inhibits the Noncanonical NF-κB Pathway to Attenuate Liver Injury and Fibrosis in BDL Rats
por: Zhu, Haoyang, et al.
Publicado: (2018) -
AMPK-dependent and independent effects of AICAR and compound C on T-cell responses
por: Rao, Enyu, et al.
Publicado: (2016) -
AICAr, a Widely Used AMPK Activator with Important AMPK-Independent Effects: A Systematic Review
por: Višnjić, Dora, et al.
Publicado: (2021)